Marc Learned
Keine laufenden Positionen mehr
Profil
Marc Learned worked as a Research Director-Metabolic Disorders at Amgen, Inc. He then served as an Associate Director at Tularik, Inc. Following that, he was the Director-Research Operations at NGM Biopharmaceuticals, Inc. from 2008 to 2013.
Prior to his industry experience, Dr. Learned worked as an Assistant Professor at the University of California, Davis.
Dr. Learned completed his undergraduate studies at the University of California, Los Angeles and obtained both his undergraduate and doctorate degrees from the University of California, Berkeley.
Ehemalige bekannte Positionen von Marc Learned
Unternehmen | Position | Ende |
---|---|---|
University of California, Davis | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
NGM BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Marc Learned
University of California, Los Angeles | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMGEN INC. | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |